ÂÜÀòÂÒÂ×

Richard Klausner

Richard (Rick) Klausner, MD, is a Founder of GRAIL. Rick is CEO of Lyell Immunopharma, Executive Chair of Mindstrong Health, and Chair of Medical Creations, Wisdo, and LifeMine.

Rick was a Founder and Director of Juno Therapeutics until its acquisition by Celgene in 2018. He is the former Senior Vice President, Chief Medical Officer and Chief Opportunity Officer of Illumina and former Executive Chairman of Audax Health. Previously, he served as Managing Partner of the Venture Capital firm, The Column Group, and was the Executive Director for Global Health of the Bill and Melinda Gates Foundation. Rick was appointed by Presidents Clinton and Bush as the eleventh Director of the U.S. National Cancer Institute between 1995 and 2001. He also served as Chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development, as well as a past president of the American Society of Clinical Investigation. He is a Fellow of the AACR Academy. Rick holds an MD from Duke Medical School.